P-e E. Morange
Boulevard Jean Moulin
Marseille, 13005, France
Marseille, 13005, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Heparin-induced thrombocytopenia: Update
Journal: La Revue de medecine interne
Published: March 03, 2021
Bilateral adrenal hemorrhage under apixaban in primary antiphospholipid syndrome
Journal: La Revue de medecine interne
Published: July 21, 2019
Impact of menstrual blood self-representation on contraceptive choice of women
Journal: Gynecologie, obstetrique, fertilite & senologie
Published: November 18, 2018
Minor allele of the factor V K858R variant protects from venous thrombosis only in non-carriers of factor V Leiden mutation.
Journal: Scientific reports
Published: August 07, 2018
Risk factors for thromboembolic disease in young women-the role of hormones
Journal: Revue des maladies respiratoires
Published: June 12, 2017
Single nucleotide polymorphisms in an intergenic chromosome 2q region associated with tissue factor pathway inhibitor plasma levels and venous thromboembolism.
Journal: Journal of thrombosis and haemostasis : JTH
Published: March 10, 2016
Genetics of Venous Thrombosis: update in 2015.
Journal: Thrombosis and haemostasis
Published: May 15, 2015
Argatroban in the management of heparin-induced thrombocytopenia: a multicenter clinical trial.
Journal: Critical care (London, England)
Published: February 23, 2015
Risk factors for venous thromboembolism in women under combined oral contraceptive. The PILl Genetic RIsk Monitoring (PILGRIM) Study.
Journal: Thrombosis and haemostasis
Published: January 16, 2015
Genetic determinants of tissue factor pathway inhibitor plasma levels.
Journal: Thrombosis and haemostasis
Published: December 15, 2014
Last Updated: 09/26/2026